High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
A Pilot Trial of High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Older Adults With HIV
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whether 16 weeks of structured high-intensity interval training (HIIT) can overcome vascular and cognitive impairments (Aim 1) to a greater extent than continuous moderate exercise. Additionally, investigator will seek to identify barriers to engagement in exercise and the participants' perceptions of the study and exercise interventions (Aim 2). This study will enroll 60 participants in Birmingham, Alabama. Data collection will occur at each visit, with baseline data collected at the initial visit with a 3-month follow-up occurring following completion of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hiv
Started Feb 2024
Longer than P75 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2023
CompletedFirst Posted
Study publicly available on registry
July 28, 2023
CompletedStudy Start
First participant enrolled
February 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
August 8, 2025
August 1, 2025
4.8 years
July 19, 2023
August 4, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in vascular function
Arterial stiffness is a continuous measure of cardiovascular disease risk.
Baseline, Up to 16 weeks, 3-months Post-Intervention
Change in cognitive function
Cognitive function will be measured using BRACE+, a neuropsychological battery
Baseline, Up to 16 weeks, 3-months Post-Intervention
Secondary Outcomes (2)
Barriers to Engagement in Exercise
Baseline
Perceptions of the Study and Exercise Interventions
Up to 16 weeks
Other Outcomes (1)
Participant Safety, Adherence to the Intervention, Retention
Through study completion, an average of 6 months
Study Arms (2)
High-Intensity Interval Training
EXPERIMENTALContinuous Moderate Exercise
ACTIVE COMPARATORInterventions
Following a 5-minute warm-up at 50% VO2peak, high and moderate-intensity exercise bouts alternate, progressing to five bouts of 4-minute high-intensity exercise (90% VO2peak), alternating with four 3-minute bouts of moderate-intensity exercise (50% VO2peak) by week 8, followed by a 5 minute cool-down. The total exercise time is 42 minutes.
Following a 4 minute warm-up at 50% VO2peak, the participant walks for up to 42 continuous minutes at 60% VO2peak, followed by a 4 minute cool-down. The total exercise time is 50 minutes.
Eligibility Criteria
You may qualify if:
- Age 50 years and older
- Sedentary lifestyle, defined as \< 150 min/wk moderate physical activity as assessed by CHAMPS questionnaire
- Neurocognitive Impairment (as assessed using the BRACE+
- Prescribed HIV ART for ≥ 12 months, with no current use of older drugs with established mitochondrial toxicity
- Able to speak, read, and write in English
- Willingness to participate in all study procedures
You may not qualify if:
- Diagnosis of mitochondrial disease
- Active substance abuse or factors preventing compliance or safety
- Uncontrolled hypertension, defined as resting BP \> 150/90 mmHG
- Chronic kidney disease
- Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
- Acute myocardial infarction identified by medical history and ECG
- Pulmonary disease requiring the use of supplemental oxygen
- Poorly controlled diabetes
- Neuropsychologically Intact
- Orthopedic problems that limit ability to perform exercise
- Simultaneous participation in another intervention trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35205, United States
Related Publications (1)
Jones R, Hankes MJ, Vickers JK, Kulik GL, Jankowski CM, Oliveira V, Khuu V, Cook PF, Li P, Vance DE, Ivankova NV, Erlandson KM, Webel AR, Buford TW, Fazeli PL. Examining High-Intensity Exercise on Cognitive and Vascular Outcomes in Older Adults Living With HIV-A Research Protocol: Design and Rationale From Two Harmonized Clinical Studies in the Deep South. J Assoc Nurses AIDS Care. 2026 Jan-Feb 01;37(1):118-132. doi: 10.1097/JNC.0000000000000591. Epub 2025 Oct 1.
PMID: 41026763DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raymond Jones, Ph.D.
University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 19, 2023
First Posted
July 28, 2023
Study Start
February 5, 2024
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
August 8, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be made available no later than the time of an associated publication or end of the funding period, whichever comes first. NACDA guarantees data will be made available for ≥10 years
- Access Criteria
- De-identified individual participant data will be deposited into NACDA as restricted, which limits access to the data to qualified investigators with who must sign a data use agreement. NACDA requires users to submit a data use agreement. NACDA will review the data request for completeness and determine if an IRB approval is needed. Anyone who has submitted an approved data request and signed data use agreement on NACDA will be given access to the data without cost, for a set period.
Participant-level deidentified data will be preserved through deposition of the data in a controlled public repository. All aggregate datasets that can be shared publicly will be deposited in the NIH/NIA Repository, National Archive of Computerized Data on Aging (NACDA).